Correspondence 0001193125-25-011429 from RAPT Therapeutics, Inc. (RAPT) (CIK 0001673772) (RAPT)
RAPT Therapeutics, Inc. (RAPT) (CIK 0001673772)
Date: Jan. 23, 2025 · CIK: 0001673772 · Accession: 0001193125-25-011429
AI Filing Summary & Sentiment
File numbers found in text: 333-284388
Letter
RAPT THERAPEUTICS, INC.
561 Eccles Avenue
South San Francisco, California 94080
(650) 489-9000
January 23, 2025
VIA EDGAR
Securities and Exchange Commission
Office of Finance
Division of Corporation Finance
100 F. Street N.E.
Washington, D.C. 20549-3010
RE: RAPT Therapeutics, Inc.
Registration Statement on Form S-3 (File No. 333-284388)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
RAPT Therapeutics, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-284388) (the “Registration Statement”) to become effective on Monday, January 27, 2025, at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Courtney M.W. Tygesson of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Courtney M.W. Tygesson of Cooley LLP, counsel to the Registrant, at (312) 881-6680, or in her absence, Alaina DeBona at (312) 881-6605.
[Remainder of page intentionally left blank]
Very truly yours,
RAPT THERAPEUTICS,
INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP RAPT THERAPEUTICS, INC. 561 Eccles Avenue South San Francisco, California 94080 (650) 489-9000 January 23, 2025 VIA EDGAR Securities and Exchange Commission Office of Finance Division of Corporation Finance 100 F. Street N.E. Washington, D.C. 20549-3010 RE: RAPT Therapeutics, Inc. Registration Statement on Form S-3 (File No. 333-284388) Request for Acceleration of Effective Date Ladies and Gentlemen: RAPT Therapeutics, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-284388) (the “Registration Statement”) to become effective on Monday, January 27, 2025, at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Courtney M.W. Tygesson of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Courtney M.W. Tygesson of Cooley LLP, counsel to the Registrant, at (312) 881-6680, or in her absence, Alaina DeBona at (312) 881-6605. [Remainder of page intentionally left blank] Very truly yours, RAPT THERAPEUTICS, INC. By: /s/ Brian Wong Name: Brian Wong Title: President and Chief Executive Officer cc: Michael Listgarten, General Counsel, RAPT Therapeutics, Inc. Courtney M.W. Tygesson, Cooley LLP Alaina DeBona, Cooley LLP